MediSieve Founder Honoured as MIT Technology Review’s Innovator Under 35

Dr George Frodsham, CEO and founder of innovative MedTech company, MediSieve, has been selected as one of MIT Technology Review’s Innovators Under 35 Europe 2019.

Innovators Under 35 is an annual list that recognises outstanding innovators who are younger than 35.

Dr Frodsham said, “It is a real honour to be selected as one of the Innovators Under 35 by such a prestigious institution as MIT. It is further validation of the fantastic work being carried out by the MediSieve team. I am excited to join the community of other innovators from 2019 and previous years and look forward to engaging further with them and MIT.”

This monumental achievement now means that Dr Frodsham joins the global community of innovators, pioneers and social changemakers curated by MIT Technology Review.

The awards span a wide range of fields, including biotechnology, materials, computer hardware, energy, transportation, communications, and the Internet. The panel consists of MIT Technology Review editors and experts in the tech ecosystem who evaluate and select the best projects for this year's edition.

Innovators Under 35 looks for individuals whose superb technical work promises to shape the coming decades. Their goal is to recognise the development of new technology or the creative application of existing technologies to solve the world’s biggest problems. They reward ingenious and elegant work that matters to the world at large—not just to peers in a particular field or industry.

MediSieve is the medical device company which is developing ‘magnetic blood filtration’. Their technology can potentially transform the treatment of blood-borne diseases including sepsis, leukaemia, and malaria in a process that’s similar to dialysis.  

2019 has already been a year to remember for MediSieve. The company recently announced that they were a winner of the ‘Breakthrough Medical or Healthcare Device Award’ in the Beanstalks competition 2019. Earlier this year, Dr Frodsham won the Early Career Impact Award at the BBSRC Innovator of the Year Awards 2019. The company also won the highly competitive award category of Investment Achievement at the MedTech London Awards 2019, part of the annual Mayor of London Awards.
 

For more information on MediSieve please visit: www.medisieve.com.

ENDS 

To find out more contact: pr@redheadpr.co.uk  

Editors Notes
 

Dr George Frodsham founded MediSieve in 2015. Since then the company has been on a growth trajectory, which includes accolades such as:

·         Winner of the ‘Breakthrough Medical or Healthcare Device Award’ in the Beanstalks competition 2019

·         Dr Frodsham won the Early Career Impact Award at the BBSRC Innovator of the Year Awards 2019

·         Won the highly competitive award category of Investment Achievement at the medtech London Awards 2019, part of the annual Mayor of London Awards

·         Won the highly competitive award category of Investment Achievement at the recent medtech London Awards 2019

·         Received two grants from Innovate UK in 2019, worth a total of around £1.56m. One large biomedical catalyst grant to progress development of a severe sepsis product, developing five magnetic particles to remove different sepsis targets. Another SRBI grant enables further focus on one of those particles and how it can be used to remove anti-microbial resistant (AMR) bacteria from a patient’s bloodstream

·         1st Runner Up for Best Business Plan Award at biopharm America in 2019

·         Finalist in the inaugural Medtech Insight Awards 2018, in the category of Innovative Team of the Year

·         Received over £1.75 million in funding in 2018 from a mix of both old and new investors

·         Nominated in the Healthcare Application category of the TCT Magazine 2017 Awards

·         Received a Phase 1 EU SME Instrument grant of €50,000 in 2016

·         Reached the final round of masschallenge UK 2016, the global non-profit startup accelerator and competition for high-impact, early-stage entrepreneurs

·         Secured £350,000 in seed funding from angel investors with expertise in the medical device and healthcare industries - they include leading patent attorneys, former ceos and successful entrepreneurs in the field

·         Received a Pathfinder Award from the Wellcome Trust - this provided MediSieve with £102,000 to fund a 12-month project to manufacture and test clinical prototypes of its device

·         Won an Innovate UK Smart 2015/16 Proof of Concept Award grant worth £100,000 

·         Taken the runner-up spot at Pitch@Palace 5.0. Held at St. James's Palace, London, the event saw UK entrepreneurs pitch to around 300 ceos, angel investors, mentors and key business partners

·         Presented at the Royal Society of Medicine's 12th Medical Innovations Summit

·         Been featured in The Telegraph and many other major journals and publications